diazepam FDA Alerts
The FDA Alert(s) below may be specifically about diazepam or relate to a group or class of drugs which include diazepam.
MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. Following is a list of possible medication recalls, market withdrawals, alerts and warnings. For the latest FDA MedWatch alerts, go here.
Recent FDA Alert(s) for diazepam
Meridian Medical Technologies Auto-Injectors: Extension of Expiration Dates
Nov 22, 2013
Audience: Emergency Medicine, Pharmacy
including Auto-Injectors for
DuoDote (atropine/pralidoxime chloride)
ISSUE: FDA is aware of a disruption in supply to health care providers and emergency response personnel of Atropen (atropine), DuoDote (atropine/pralidoxime chloride), morphine sulfate, pralidoxime chloride, and diazepam auto-injectors manufactured by Meridian Medical Technologies, a Pfizer Inc. company. FDA and Meridian are working together to resolve the disruption as quickly as possible, but it is unclear how long this disruption may persist.
FDA concluded that it was scientifically supported that certain lots of DuoDote can be used for an additional year beyond the manufacturer’s original labeled expiration date. FDA is continuing to assess whether these identified lots of DuoDote can receive further expiration date extensions if needed, and whether additional lots of DuoDote that were not listed in FDA’s September 5, 2013, memo can have their expiration date extended.
FDA is currently reviewing data for the potential use of Atropen (atropine), DuoDote (atropine/pralidoxime chloride), morphine sulfate, pralidoxime chloride, and diazepam auto-injectors beyond their labeled expiration dates in order to mitigate any potential shortages of these medically necessary drugs.
RECOMMENDATIONS: FDA will provide additional information about use of these products beyond the labeled expiration date in the coming weeks. Until FDA provides additional information, these expired auto-injectors may be used for patient care under emergency situations when no other product is available.
Health care providers and emergency response personnel who have any of the auto-injectors manufactured by Meridian identified above that are nearing or beyond the labeled expiration date should retain the products until FDA is able to provide additional information regarding the continued use of these products.
[11/22/2013 - Drug Safety Statement - FDA]
[09/05/2013 - Memorandum to Pfizer/Meridian Medical Technologies - FDA]
More diazepam Resources
- Diazepam Consumer Information
- Valtoco Nasal Spray Consumer Information
- Diazepam injection Consumer Information
- Diazepam nasal Consumer Information
- Diazepam rectal Consumer Information
- Diazepam Injection Consumer Information
- Diazepam Nasal Spray Consumer Information
- Diazepam Tablets Consumer Information
- Diazepam Oral Concentrate Consumer Information
- Diazepam Oral Solution Consumer Information
- Diazepam Rectal Gel Consumer Information
- Diazepam Advanced Consumer Information
- Diazepam Injection Advanced Consumer Information
- Diazepam Rectal Advanced Consumer Information
- Diazepam AHFS DI Monograph
- Diazepam Prescribing Information
- Diazepam Autoinjector Prescribing Information
- Diazepam Injection Prescribing Information
- Diazepam Oral Solution Concentrate Prescribing Information
- Diazepam Rectal Gel Prescribing Information
- Diazepam Solution Prescribing Information
- Diazepam Tablet Prescribing Information
- Diazepam A-Z Drug Facts